Success Factors for Remote and Hybrid Decentralised Trials

Amidst the enthusiasm surrounding the advantages and efficiencies promised by Decentralised Clinical Trials (DCTs), encompassing remote or hybrid trials, an imperative gap remains – the need for deeper understanding, agreement, and standardization of optimal practices and protocol.

When executed thoughtfully, accounting for several factors, DCTs promise improved and more representative evaluations of treatment efficacy and benefits. The successful execution of DCTs is contingent upon addressing various challenges. These challenges encompass participant recruitment, effective adoption and execution at trial sites, seamless technology integration, and navigating evolving regulatory requirements.

To pave the way for an effective global rollout of DCT trials, it is incumbent on sponsors to meticulously address and develop comprehensive strategies around each of these pivotal aspects. 

This webinar puts a spotlight on the success factors from a site, technology and service provider perspectives with a fully remote, hybrid and conventional 3-arm adaptive trial in Europe in Diabetes Type 2 (RADIAL) as an example.

Presenters: 

• Karl Landert, Managing Director – DCT, Cambridge Cognition
• Ute Bertelsmann, Site Network Director, Pratia
• Paul Bodfish, Consultant, MRN